SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 30.63 CNY -1.83% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SonoScape Medical Corp
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Accrued Liabilities
ÂĄ143.9m
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accrued Liabilities
ÂĄ132.8m
CAGR 3-Years
41%
CAGR 5-Years
42%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accrued Liabilities
ÂĄ321.1m
CAGR 3-Years
38%
CAGR 5-Years
42%
CAGR 10-Years
49%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accrued Liabilities
ÂĄ3.9B
CAGR 3-Years
24%
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Accrued Liabilities
ÂĄ116.9m
CAGR 3-Years
55%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accrued Liabilities
ÂĄ879.6m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
13.2B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
49.55 CNY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Accrued Liabilities?
Accrued Liabilities
143.9m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Accrued Liabilities amounts to 143.9m CNY.

What is SonoScape Medical Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
22%

Over the last year, the Accrued Liabilities growth was 24%. The average annual Accrued Liabilities growth rates for SonoScape Medical Corp have been 15% over the past three years , 22% over the past five years .

Back to Top